A polygenic resilience score moderates the genetic risk for schizophrenia.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsHess, Jonathan L
Tylee, Daniel S
Børglum, Anders D
Als, Thomas D
Mortensen, Preben Bo
Hougaard, David M
Greenwood, Tiffany A
Tsuang, Ming T
Edenberg, Howard J
Faraone, Stephen V
Glatt, Stephen J
MetadataShow full item record
CitationHess JL, Tylee DS, Mattheisen M; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH), Børglum AD, Als TD, Grove J, Werge T, Mortensen PB, Mors O, Nordentoft M, Hougaard DM, Byberg-Grauholm J, Bækvad-Hansen M, Greenwood TA, Tsuang MT, Curtis D, Steinberg S, Sigurdsson E, Stefánsson H, Stefánsson K, Edenberg HJ, Holmans P, Faraone SV, Glatt SJ. A polygenic resilience score moderates the genetic risk for schizophrenia. Mol Psychiatry. 2021 Mar;26(3):800-815. doi: 10.1038/s41380-019-0463-8.
AbstractBased on the discovery by the Resilience Project (Chen R. et al. Nat Biotechnol 34:531-538, 2016) of rare variants that confer resistance to Mendelian disease, and protective alleles for some complex diseases, we posited the existence of genetic variants that promote resilience to highly heritable polygenic disorders1,0 such as schizophrenia. Resilience has been traditionally viewed as a psychological construct, although our use of the term resilience refers to a different construct that directly relates to the Resilience Project, namely: heritable variation that promotes resistance to disease by reducing the penetrance of risk loci, wherein resilience and risk loci operate orthogonal to one another. In this study, we established a procedure to identify unaffected individuals with relatively high polygenic risk for schizophrenia, and contrasted them with risk-matched schizophrenia cases to generate the first known "polygenic resilience score" that represents the additive contributions to SZ resistance by variants that are distinct from risk loci. The resilience score was derived from data compiled by the Psychiatric Genomics Consortium, and replicated in three independent samples. This work establishes a generalizable framework for finding resilience variants for any complex, heritable disorder.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download
- Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.
- Authors: Bigdeli TB, Ripke S, Bacanu SA, Lee SH, Wray NR, Gejman PV, Rietschel M, Cichon S, St Clair D, Corvin A, Kirov G, McQuillin A, Gurling H, Rujescu D, Andreassen OA, Werge T, Blackwood DH, Pato CN, Pato MT, Malhotra AK, O'Donovan MC, Kendler KS, Fanous AH, Schizophrenia Working Group of the Psychiatric Genomics Consortium.
- Issue date: 2016 Mar
- Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia.
- Authors: Wang SH, Hsiao PC, Yeh LL, Liu CM, Liu CC, Hwang TJ, Hsieh MH, Chien YL, Lin YT, Chandler SD, Faraone SV, Laird N, Neale B, McCarroll SA, Glatt SJ, Tsuang MT, Hwu HG, Chen WJ
- Issue date: 2018 Jan
- Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway.
- Authors: Nicodemus KK, Hargreaves A, Morris D, Anney R, Schizophrenia Psychiatric Genome-wide Association Study (GWAS) Consortium., Wellcome Trust Case Control Consortium 2., Gill M, Corvin A, Donohoe G
- Issue date: 2014 Jul 1
- Association Between Substance Use Disorder and Polygenic Liability to Schizophrenia.
- Authors: Hartz SM, Horton AC, Oehlert M, Carey CE, Agrawal A, Bogdan R, Chen LS, Hancock DB, Johnson EO, Pato CN, Pato MT, Rice JP, Bierut LJ
- Issue date: 2017 Nov 15
- Common polygenic variation contributes to risk of schizophrenia and bipolar disorder.
- Authors: International Schizophrenia Consortium., Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P
- Issue date: 2009 Aug 6